Accelmed
Accelmed Partners is a private equity and growth capital firm founded in 2009, with headquarters in Miami, Florida, and additional offices in River Edge, New Jersey, and Tel Aviv, Israel. The firm specializes in investments within the health technology sector, focusing on medical devices, diagnostics, digital health, and technology-enabled services. Accelmed typically invests between $10 million and $100 million in companies that have sales ranging from $10 million to $80 million. The firm aims to support both private and public companies that have demonstrated market potential and possess proven clinical data. By collaborating closely with management teams, Accelmed assists its portfolio companies in transitioning from clinical stages to profitable operations, while also addressing complexities in capital structures and fostering growth. The firm is particularly interested in companies based in the United States, Canada, Israel, and Europe.
EndoGastric Solutions, Inc. is a medical device company focused on developing and commercializing innovative surgical technologies for the treatment of gastrointestinal diseases, particularly gastroesophageal reflux disease (GERD). The company is known for its Transoral Incisionless Fundoplication (TIF®) procedure, which provides a minimally invasive alternative to traditional surgical methods by allowing treatment without external incisions. Key products include the EsophyX technology, which facilitates transoral reconstructive surgery, and the SerosaFuse Fasteners, designed for secure tissue attachment. Additionally, EndoGastric Solutions offers training courses for surgeons and a range of consultative support services. Founded in 2002 and headquartered in Redmond, Washington, the company also has an office in San Mateo, California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.